Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Alzheimer Disease and Associated Disorders
|
March 13, 2018
When Decrease Aβ1-42 in CSF May Not Mean Alzheimer's Disease: Insights From Two Case Reports With Early Onset Dementia
Filipa Ladeira, Gonçalo Cação, Ana P Correia, et al.
Sleep Medicine
|
August 28, 2020
Polysomnographic predictors of sleep, motor and cognitive dysfunction progression in Parkinson's disease: a longitudinal study
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Movement Disorders Clinical Practice
|
August 18, 2021
Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Acta Medica Portuguesa
|
October 14, 2017
Letter to the Editor: Medication-Overuse Headache is Common in Portuguese Migraineurs
Marcelo Duarte Mendonça, André Caetano, Manuel Salavisa, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 7, 2019
Motor and non-motor function predictors of mortality in Parkinson's disease
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Multiple Sclerosis and Related Disorders
|
March 2, 2021
Seroconversion rate following HBV vaccination in clinical practice: The role of age and DMT treatment
Patrícia Faustino, Maria Coutinho, Lia Leitão, et al.
Journal of Sleep Research
|
August 11, 2020
Do dreams tell the future? Dream content as a predictor of cognitive deterioration in Parkinson's disease
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Movement Disorders Clinical Practice
|
August 8, 2022
Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non-Motor Symptoms in Parkinson's Disease
Bruna Meira, Marco Fernandes, Manuel Salavisa, et al.
Clinical Neuropharmacology
|
May 16, 2023
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal
Mónica Santos, João Sequeira, Pedro Abreu, et al.
Clinical Neurology and Neurosurgery
|
July 16, 2019
A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal
Filipa Ladeira, Luís Braz, Paula Salgado, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Alzheimer Disease and Associated Disorders
|
March 13, 2018
When Decrease Aβ1-42 in CSF May Not Mean Alzheimer's Disease: Insights From Two Case Reports With Early Onset Dementia
Filipa Ladeira, Gonçalo Cação, Ana P Correia, et al.
Sleep Medicine
|
August 28, 2020
Polysomnographic predictors of sleep, motor and cognitive dysfunction progression in Parkinson's disease: a longitudinal study
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Movement Disorders Clinical Practice
|
August 18, 2021
Progression in Parkinson's Disease: Variation in Motor and Non-motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health-Related Quality of Life as Assessed by Two Different Methods
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Acta Medica Portuguesa
|
October 14, 2017
Letter to the Editor: Medication-Overuse Headache is Common in Portuguese Migraineurs
Marcelo Duarte Mendonça, André Caetano, Manuel Salavisa, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
August 7, 2019
Motor and non-motor function predictors of mortality in Parkinson's disease
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Multiple Sclerosis and Related Disorders
|
March 2, 2021
Seroconversion rate following HBV vaccination in clinical practice: The role of age and DMT treatment
Patrícia Faustino, Maria Coutinho, Lia Leitão, et al.
Journal of Sleep Research
|
August 11, 2020
Do dreams tell the future? Dream content as a predictor of cognitive deterioration in Parkinson's disease
Paulo Bugalho, Filipa Ladeira, Raquel Barbosa, et al.
Movement Disorders Clinical Practice
|
August 8, 2022
Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non-Motor Symptoms in Parkinson's Disease
Bruna Meira, Marco Fernandes, Manuel Salavisa, et al.
Clinical Neuropharmacology
|
May 16, 2023
Safety and Effectiveness of Cladribine in Multiple Sclerosis: Real-World Clinical Experience From 5 Tertiary Hospitals in Portugal
Mónica Santos, João Sequeira, Pedro Abreu, et al.
Clinical Neurology and Neurosurgery
|
July 16, 2019
A multicenter, non-interventional study to evaluate the disease activity in Multiple Sclerosis after withdrawal of Natalizumab in Portugal
Filipa Ladeira, Luís Braz, Paula Salgado, et al.
Page
of 4